- Home
- RRX vs ASND Comparison
RRX vs ASND Comparison
Compare RRX & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RRX | ASND |
|---|---|---|
| Founded | 1955 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 14.7B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | RRX | ASND |
|---|---|---|
| Price | $216.59 | $237.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 16 |
| Target Price | $210.70 | ★ $281.50 |
| AVG Volume (30 Days) | ★ 1.2M | 744.9K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.69% | N/A |
| EPS Growth | ★ 42.86 | N/A |
| EPS | ★ 0.96 | N/A |
| Revenue | ★ $3,257,100,000.00 | N/A |
| Revenue This Year | $4.20 | $96.35 |
| Revenue Next Year | $12.13 | $44.91 |
| P/E Ratio | $48.99 | ★ N/A |
| Revenue Growth | ★ 5.21 | N/A |
| 52 Week Low | $127.96 | $153.49 |
| 52 Week High | $236.35 | $250.74 |
Technical Indicators
Market Signals| Indicator | RRX | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 54.70 | 53.65 |
| Support Level | $136.55 | $215.18 |
| Resistance Level | $222.63 | $244.79 |
| Average True Range (ATR) | 8.52 | 10.10 |
| MACD | 0.18 | 0.89 |
| Stochastic Oscillator | 43.97 | 62.35 |
Price Performance
Historical ComparisonAbout RRX Regal Rexnord Corporation
Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The three operating segments include Automation & Motion Control (AMC) segment; Industrial Powertrain Solutions (IPS) segment, which derives maximum revenue; and Power Efficiency Solutions (PES) segment. Geographically, the company operates in North America, Europe, Asia, and Rest of the world, of which it derives maximum revenue from North America.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.